Hepatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Hepatitis, including details on hepatitis a, b, c, causes, symptoms.

Volume 2 (2007), Issue 6 (June)

1. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
   Pathol Int, 57(6): 328-36. [Abstract] [Full-text]
2. Transmission dynamics of hepatitis E among swine: potential impact upon human infection.
   BMC Vet Res, 3: 9. [Abstract] [Full-text]
3. Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population.
   J Med Virol, 79(6): 724-33. [Abstract] [Full-text]
4. Expression of Bax, Bcl-xL and Bcl-2 proteins in relation to grade of inflammation and stage of fibrosis in chronic hepatitis C.
   Histopathology, 50(7): 928-35. [Abstract] [Full-text]
5. Effectiveness and hepatotoxicity of statins in men seropositive for hepatitis C virus.
   Pharmacotherapy, 27(6): 845-51. [Abstract] [Full-text]
6. Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care System.
   Pharmacotherapy, 27(6): 813-24. [Abstract] [Full-text]
7. Ongoing subclinical infection of hepatitis E virus among blood donors with an elevated alanine aminotransferase level in Japan.
   J Med Virol, 79(6): 734-42. [Abstract] [Full-text]
8. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti-HBe.
   J Med Virol, 79(6): 683-93. [Abstract] [Full-text]
9. Serum levels of anti-NS4a and anti-NS5a predict treatment response of patients with chronic hepatitis C.
   J Med Virol, 79(6): 701-13. [Abstract] [Full-text]
10. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    J Med Virol, 79(6): 694-700. [Abstract] [Full-text]
11. Molecular epidemiology of hepatitis A in St. Petersburg, Russia, 1997-2003.
    J Med Virol, 79(6): 657-62. [Abstract] [Full-text]
12. Hepatitis B virus genotypes in children and adolescents in Japan: before and after immunization for the prevention of mother to infant transmission of hepatitis B virus.
    J Med Virol, 79(6): 670-5. [Abstract] [Full-text]
13. Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B.
    J Med Virol, 79(6): 663-9. [Abstract] [Full-text]
14. PON1 status in haemodialysis patients and the impact of hepatitis C infection.
    Clin Biochem, 40(9): 609-14. [Abstract] [Full-text]
15. Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy.
    Hepatology, 45(6): 1382-9. [Abstract] [Full-text]
16. Hepatitis B x antigen up-regulates vascular endothelial growth factor receptor 3 in hepatocarcinogenesis.
    Hepatology, 45(6): 1390-9. [Abstract] [Full-text]
17. Engulfment of apoptotic cells expressing HCV proteins leads to differential chemokine expression and STAT signaling in human dendritic cells.
    Hepatology, 45(6): 1422-32. [Abstract] [Full-text]
18. Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice.
    Hepatology, 45(6): 1400-12. [Abstract] [Full-text]
19. Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology.
    Hepatology, 45(6): 1413-21. [Abstract] [Full-text]
20. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.
    Hepatology, 45(6): 1348-54. [Abstract] [Full-text]
21. Prevalence of anti-hepatitis E virus antibodies in French blood donors.
    J Clin Microbiol, 45(6): 2009-10. [Abstract] [Full-text]
22. Viral hepatitis among male amphetamine-inhaling abusers.
    Intern Med J, 37(7): 472-7. [Abstract] [Full-text]
23. Parents' attitudes towards hepatitis B vaccination for their children. A survey comparing paper and web questionnaires, Sweden 2005.
    BMC Public Health, 7: 86. [Abstract] [Full-text]
24. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Cancer, 109(12): 2490-6. [Abstract] [Full-text]
25. Subversion of innate host antiviral strategies by the hepatitis C virus.
    Arch Biochem Biophys, 462(2): 254-65. [Abstract] [Full-text]
26. Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy.
    J Theor Biol, 247(2): 371-81. [Abstract] [Full-text]
27. Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis.
    Gastroenterology, 132(7): 2533-41. [Abstract] [Full-text]
28. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion.
    Gastroenterology, 132(7): 2340-5. [Abstract] [Full-text]
29. Paradoxical brain embolism associated with HCV-related type II mixed cryoglobulinemia.
    J Clin Neurosci, 14(8): 780-2. [Abstract] [Full-text]
30. Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation.
    Transpl Int, 20(7): 583-90. [Abstract] [Full-text]
31. The HBV drug entecavir - effects on HIV-1 replication and resistance.
    N Engl J Med, 356(25): 2614-21. [Abstract] [Full-text]
32. An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study.
    BMC Gastroenterol, 7: 17. [Abstract] [Full-text]
33. Hepatitis C in dialysed patients--what is the current optimal treatment?
    Kidney Blood Press Res, 30(3): 156-61. [Abstract] [Full-text]
34. Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection.
    J Pediatr Gastroenterol Nutr, 45(1): 75-83. [Abstract] [Full-text]
35. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV.
    J Infect Dis, 196(3): 361-70. [Abstract] [Full-text]
36. A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.
    Cancer Immunol Immunother, 56(9): 1359-66. [Abstract] [Full-text]
37. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study.
    Am J Epidemiol, 166(2): 196-203. [Abstract] [Full-text]

© 2006-2008 Hepatitis Research Today. All Rights Reserved.